Lack of effect of antacids on plasma concentrations of omeprazole given as enteric-coated granules. 1987

H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
Department of Gastroenterology, Free University Hospital, Amsterdam, The Netherlands.

Twelve male volunteers were studied after a single oral dose of 20 mg omeprazole given as enteric-coated granules with and without concomitant administration of 10 ml of a potent liquid antacid (buffering capacity 56.6 mmol 10 ml-1) under fasting conditions. No statistically significant differences were detected in median Cmax (0.41 approximately equal to 0.53 mumol l-1), the geometric mean AUC (0.80 approximately equal to 0.81 mumol l-1 h) or median tmax (1.25 h), with and without antacid.

UI MeSH Term Description Entries
D008297 Male Males
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000863 Antacids Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. Alkalinizing Agent,Antacid,Alkalinizing Agents,Agent, Alkalinizing,Agents, Alkalinizing

Related Publications

H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
January 2002, Bollettino chimico farmaceutico,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
March 1991, British journal of clinical pharmacology,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
June 1979, British medical journal,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
April 1997, Digestive diseases and sciences,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
August 1976, Rheumatology and rehabilitation,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
January 1977, The Journal of international medical research,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
October 1998, International journal of clinical pharmacology and therapeutics,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
January 2009, BMJ case reports,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
June 2001, Methods and findings in experimental and clinical pharmacology,
H A Tuynman, and H P Festen, and K Röhss, and S G Meuwissen
March 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!